Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 38 Lyon 27 Montpellier 21 Marseille 19 Lille 19
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris602 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild66 AstraZeneca64 Institut National de la Santé Et de la Recherche Médicale, France63 Clear sponsor filter
Site location
Paris38 Lyon27 Montpellier21 Marseille19 Lille19
All 66 locations
Target enrolment
to

Trials with a site in Paris

38 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Eli Lilly and Company
Phase 2
606
Brest, Cholet, Créteil, La Tronche, Lyon, Marseille, Montpellier, Paris
2026-08-07
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Lille, Paris
2026-05-28
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
DrugRituximab
Eli Lilly and Company
Phase 1
460
Nantes, Paris, Pessac, Pierre-Bénite, Toulouse
2026-04-17
Recruiting
Eli Lilly and Company
Phase 3
300
Bron, Corbeil-Essonnes, Marseille, Paris, Toulouse
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
150
Bron, Corbeil-Essonnes, Lille, Marseille, Paris, Toulouse
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
1,205
Angers, Chambray-lès-Tours, Lomme, Nice, Paris, Rennes
2025-10-31
Recruiting
Eli Lilly and Company
Phase 2
531
Aix-en-Provence, Brest, Cholet, Le Chesnay, Le Kremlin-Bicêtre, Montfermeil, Paris, Pessac
2025-10-22
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT07114601Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms
Eli Lilly and Company
Phase 1
421
Paris, Saint-Herblain
2025-08-06
Recruiting
Eli Lilly and Company
Phase 3
350
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen
2025-06-26
Active, closed
Eli Lilly and Company
Phase 3
465
Bois-Guillaume, Corbeil-Essonnes, Grenoble, Le Creusot, Marseille, Paris, Toulouse, Vénissieux
2025-05-12
Recruiting
Eli Lilly and Company
Phase 3
700
Bron, La Tronche, Lyon Cedex08, Marseille, Nice, Paris, Pessac, Poitiers
2025-03-27
Active, closed
Eli Lilly and Company
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2024-10-25
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
DrugsNab-paclitaxel·Pemetrexed·Paclitaxel·Cisplatin
Eli Lilly and Company
Phase 1
340
Bordeaux, Paris, Villejuif
2024-09-19
Recruiting
Eli Lilly and Company
Phase 3
300
Angers, Bron, Lille, Marseille, Paris, Toulouse
2024-06-03
Recruiting
Eli Lilly and Company
Phase 3
90
Paris
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
1,264
Avignon, Bron, Lille, Lyon Cedex08, Nice, Paris, Pessac, Poitiers
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
595
Brest, Marseille, Nantes, Nice, Paris, Tours
2023-02-27
Active, closed
Eli Lilly and Company
Phase 3
15,374
Corbeil-Essonnes, La Tronche, Le Coudray, Le Creusot, Limoges, Nice, Paris, Pierre-Bénite
2022-10-11
Active, closed
Eli Lilly and Company
Phase 1
260
Lyon, Paris, Saint-Herblain, Strasbourg, Villejuif
2022-05-11
Active, closed
Eli Lilly and Company
Phase 3
152
Lyon, Marseille, Rouen, Le Plessis-Robinson, Villejuif, Paris
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
874
Strasbourg, La Chaussée-Saint-Victor, Besançon, Saint-Cloud, Montpellier, Le Mans, Bayonne, Paris
2021-10-04
Active, closed
Eli Lilly and Company
Phase 3
101
Bron, Montpellier, Le Kremlin-Bicêtre, Poitiers, Paris
2021-04-13
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2020-11-19
Active, closed
Eli Lilly and Company
Phase 1
71
Lyon, Paris
2020-06-11
Active, closed
Eli Lilly and Company
Phase 3
261
Lyon, Marseille, Montpellier, La Tronche, Clermont-Ferrand, Paris
2020-02-17
Active, closed
Eli Lilly and Company
Phase 3
58
Bron, Le Kremlin-Bicêtre, Nîmes, Paris, Poitiers
2020-02-12
Recruiting
Eli Lilly and Company
Phase 2
105
Bordeaux, Lyon, Paris
2020-01-22
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
Paris, Strasbourg
2019-12-10
Active, closed
Eli Lilly and Company
Phase 3
30
Le Kremlin-Bicêtre, Paris, Poitiers
2019-10-16
Recruiting
Eli Lilly and Company
Phase 3
190
Bron, Le Kremlin-Bicêtre, Nîmes, Paris, Poitiers
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Active, closed
Eli Lilly and Company
Phase 1/2
857
Bordeaux, Lyon, Marseille, Montpellier, Villejuif, Paris
2017-05-02
Active, closed
Eli Lilly and Company
Phase 1
223
Paris, Lille, Villejuif
2016-11-21
Active, closed
Eli Lilly and Company
Phase 3
545
Montpellier, La Tronche, Lille, Poitiers, Paris
2015-05-06
Active, closed
Eli Lilly and Company
Phase 2
110
Paris
2012-05-22
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

19 of the 38 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 38 studies
PhaseStudiesRecruitingShare
Phase 3231260.5%
Phase 19423.7%
Phase 25313.2%
Phase 1/2102.6%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
Eli Lilly and Company3819
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.